Frontlight ResearchEarly access
Glioblastoma trials in New Zealand
3 of 4 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Not yet taking people in New ZealandStudy of Olutasidenib and Temozolomide in HGG
- Where
- Auckland
- Age
- 12 years to 39 years
- People
- 60 worldwide
- Run by
- Rigel Pharmaceuticals
See details and how to joinNCT06161974 - Early phase 1Not yet taking people in New ZealandLorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Where
- Auckland
- Age
- 1 year to 21 years
- People
- 15 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT06333899 - Phase 2Not yet taking people in New ZealandStudy of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Where
- Auckland
- Age
- 12 months to 39 years
- People
- 120 worldwide
- Run by
- Nationwide Children's Hospital
See details and how to joinNCT05843253